International Drug Development Technopole Company Profile

12:28 EDT 21st June 2018 | BioPortfolio

IDD’s expertise is based on 25 years experience in these main fields of activity: prescription drugs, generics, OTC, herbal medicine, dermatology and cosmetics, nutritional and dietary supplements, medical and surgical instrumentation


27, chemin des Peupliers
BP 66 - 69572


Phone: 33 (0)4 72 17 27 11
Fax: 33 (0)4 78 35 76 48

News Articles [2132 Associated News Articles listed on BioPortfolio]

Cancer drug development award given to Jean-Charles Soria

(European Society for Medical Oncology) The TAT 2018 Honorary Award for cancer drug development has been granted to Professor Jean-Charles Soria, for his pioneering role in cancer drug development acr...

international business communication, scientists, conferences, pre-clinical, genomics, research and development

Provider of, drug discovery, technology, assay, development, genomic data, automation, robotics, toxicology, tutorials, plenary sessions

Study: Drug To Treat Bleeding May Benefit Some Stroke Patients

ArticlePatients with stroke caused by bleeding on the brain may benefit from receiving a drug currently used to treat blood loss from major trauma and bleeding after childbirth, an international trial...

ACG exhibits wide range of capsule solutions

ACG Capsules is showcasing its range of solutions at CPhI North America, an international platform that brings together Pharma industry s leaders from drug development, drug manufacturing and biomanuf...

AstraZeneca Collaborates With Swedish Biotech To Speed Up Drug Development

AstraZeneca collaborates with Swedish firm Pelago Bioscience to develop assay that increases the speed and efficiency of drug development.  Pelago, a Karolinska Institute spin-off, studies the intera...

New Tool Analyzes Disease And Drug Effects With Unprecedented Accuracy And Consistency

NewsIonStar could upend industry standards, and quicken medical diagnosis and drug development.

International experts agree on need for human-relevant research to improve drug discovery

The average pre-approval cost of research and development for a successful drug is estimated to be US$2.6 billion and the number of new drugs approved per billion US dollars spent has halved roughly e...

Migraine drug could prove effective against nerve agents

Drug development company Proniras has entered a contract with the US Biomedical Advanced Research and Development Authority (BARDA) to explore...Read More... The post Migraine drug could prove effecti...

Drugs and Medications [426 Associated Drugs and Medications listed on BioPortfolio]

Pvp iodine prep pad [Professional Disposables International, Inc.]

Drug Facts

Sani professional brand sani-hands for kids [Profesional Disposables International, Inc.]


Muscle and joint vanishing scent [LIFElabs, a Division of Atico International USA, INC.]

LIFElabs, a Division of Atico International USA, INC.

Sani-hands [Professional Disposables International, Inc.]


Pdi sani-hands for kids [Professional Disposables International, Inc.]


PubMed Articles [5204 Associated PubMed Articles listed on BioPortfolio]

A qualitative examination of the effects of international counter-drug interdictions.

The purpose of this study is to utilize unique qualitative data to determine the effects of sporadic international drug interdictions on drug trafficking, and to assess whether the responses of drug t...

Recommendations toward a human pathway-based approach to disease research.

Failures in the current paradigm for drug development have resulted in soaring research and development costs and reduced numbers of new drug approvals. Over 90% of new drug programs fail, the majorit...

Is the pharmaceutical industry's preoccupation with the monotherapy drug model stifling the development of effective new drug therapies?

Drug discovery and development is heavily biased towards the development of monotherapies. Screening, testing, and evaluation of mono-entity drugs are generally much simpler than drug combinations, an...

Next-generation sequencing in drug development: target identification and genetically stratified clinical trials.

Next-generation sequencing (NGS) enabled high-throughput analysis of genotype-phenotype relationships on human populations, ushering in a new era of genetics-informed drug development. The year 2017 w...

A fragmented code: The moral and structural context for providing assistance with injection drug use initiation in San Diego, USA.

Injection drug use initiation is shaped by social networks and structural contexts, with people who inject drugs often assisting in this process. We sought to explore the norms and contexts linked to ...

Clinical Trials [4754 Associated Clinical Trials listed on BioPortfolio]

Effectiveness Study of the International Child Development Program

The objective of this study is to evaluate the effect of the International Child Development Program (ICDP). Research questions to be answered: 1. Does the ICDP affect children's psycho...

Effect Evaluation of The International Child Development Programme (ICDP)

This study evaluate if a parental guidance programme based on the International Child Development Programme (ICDP) offered to the general Norwegian population, has an effect on caregivers,...

The Malmö International Brother Study (MIBS)

Existing data support the concept that a genetic predisposition for inhibitor development exists. The aim of the Malmö International Brother Study (MIBS) is to evaluate genetic factors a...

FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

Drug-resistant tuberculosis is becoming a major problem for the whole humanity, and development of new Anti-TB drugs is of great importance. Since Kazakhstan is a country with the high bur...

Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Pharmaceutical Industry (IDI), Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Prodactariv 60 mg F.C.T (International Drug Agency for Pha...

Companies [4374 Associated Companies listed on BioPortfolio]

International Drug Development Technopole

IDD’s expertise is based on 25 years experience in these main fields of activity: prescription drugs, generics, OTC, herbal medicine, dermatology and cosmetics, nutritional and dietary supplements, ...

Montpellier Méditerranée Technopole

France's fastest growing city and jewel in the crown of the Mediterranean high-technology sunbelt.If you are looking to develop your business in Southern Europe, Montpellier Technopole can help.Take a...

Locum International

The Locum International Group is a limited Research Association comprising of :(a.) A Pharmaceutical Research and Development Company with extensive experience in product development, manufacturing, r...

Laval Technopole


Biosource International Incorporated

Biosource International, Inc. is a broad based life sciences company focused on providing solutions in the areas of functional proteomics and advanced drug discovery through the development, manufactu...

More Information about "International Drug Development Technopole" on BioPortfolio

We have published hundreds of International Drug Development Technopole news stories on BioPortfolio along with dozens of International Drug Development Technopole Clinical Trials and PubMed Articles about International Drug Development Technopole for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of International Drug Development Technopole Companies in our database. You can also find out about relevant International Drug Development Technopole Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record